Published in Proc Natl Acad Sci U S A on July 02, 2008
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathog (2010) 2.80
Viral shape-shifting: norovirus evasion of the human immune system. Nat Rev Microbiol (2010) 2.53
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
From carbohydrate leads to glycomimetic drugs. Nat Rev Drug Discov (2009) 2.13
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog (2012) 2.02
Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog (2010) 2.02
Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A (2010) 1.96
The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One (2009) 1.89
Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A (2009) 1.82
Noroviral P particle: structure, function and applications in virus-host interaction. Virology (2008) 1.75
Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol (2011) 1.73
Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): a review. Vet Res (2012) 1.71
Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol (2009) 1.70
Pathogenesis of noroviruses, emerging RNA viruses. Viruses (2010) 1.67
Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses. J Virol (2010) 1.61
Qualitative and quantitative analysis of the binding of GII.4 norovirus variants onto human blood group antigens. J Virol (2011) 1.61
Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori. Cell Host Microbe (2016) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface. PLoS Pathog (2015) 1.49
Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis (2013) 1.47
Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol (2010) 1.46
Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J Virol (2011) 1.43
Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One (2009) 1.42
Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J Virol (2013) 1.39
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog (2011) 1.31
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology (2010) 1.25
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Norwalk virus-like particles as vaccines. Expert Rev Vaccines (2010) 1.23
Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol (2012) 1.21
Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15
High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain. J Virol (2010) 1.13
A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles. Immunology (2012) 1.12
Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One (2013) 1.10
Structural basis for the recognition of Lewis antigens by genogroup I norovirus. J Virol (2012) 1.09
Structure of a SusD homologue, BT1043, involved in mucin O-glycan utilization in a prominent human gut symbiont. Biochemistry (2009) 1.08
Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan. J Virol (2010) 1.07
Structural basis for norovirus inhibition and fucose mimicry by citrate. J Virol (2011) 1.05
Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol (2010) 1.05
Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens. J Virol (2012) 1.02
The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission. PLoS Pathog (2009) 1.02
Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine (Lond) (2012) 0.99
Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects. J Virol (2013) 0.98
Glycosphingolipids as receptors for non-enveloped viruses. Viruses (2010) 0.98
Crystal structure of the avian astrovirus capsid spike. J Virol (2013) 0.96
Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel (2014) 0.95
Norovirus binding to intestinal epithelial cells is independent of histo-blood group antigens. PLoS One (2013) 0.91
Gangliosides are ligands for human noroviruses. J Am Chem Soc (2014) 0.90
Bovine norovirus: carbohydrate ligand, environmental contamination, and potential cross-species transmission via oysters. Appl Environ Microbiol (2010) 0.90
Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes. PLoS One (2013) 0.89
Histo-blood group antigen assay for detecting noroviruses in water. Appl Environ Microbiol (2008) 0.88
Marked genomic diversity of norovirus genogroup I strains in a waterborne outbreak. Appl Environ Microbiol (2012) 0.88
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol (2013) 0.87
Genogroup IV and VI canine noroviruses interact with histo-blood group antigens. J Virol (2014) 0.87
Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J Virol (2014) 0.86
Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections. PLoS One (2013) 0.86
A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine (2013) 0.86
Affinities of recombinant norovirus P dimers for human blood group antigens. Glycobiology (2012) 0.86
Molecular Evolution of the Capsid Gene in Norovirus Genogroup I. Sci Rep (2015) 0.85
Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol (2014) 0.85
Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj J (2009) 0.85
Molecular evolution of the capsid gene in human norovirus genogroup II. Sci Rep (2016) 0.85
Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol (2014) 0.84
The formation of P particle increased immunogenicity of norovirus P protein. Immunology (2012) 0.84
Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses. J Virol (2014) 0.83
Branched-linear and agglomerate protein polymers as vaccine platforms. Biomaterials (2014) 0.83
Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization. J Virol (2014) 0.83
Relationship between genotypes and serotypes of genogroup 1 recoviruses: a model for human norovirus antigenic diversity. J Gen Virol (2014) 0.82
Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol (2014) 0.81
Affinities of human histo-blood group antigens for norovirus capsid protein complexes. Glycobiology (2014) 0.81
Tulane virus recognizes sialic acids as cellular receptors. Sci Rep (2015) 0.80
Norovirus recognition sites on histo-blood group antigens. Front Microbiol (2012) 0.79
Antigenic Relatedness of Norovirus GII.4 Variants Determined by Human Challenge Sera. PLoS One (2015) 0.79
Expression of the murine norovirus (MNV) ORF1 polyprotein is sufficient to induce apoptosis in a virus-free cell model. PLoS One (2014) 0.79
A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus. Vaccine (2016) 0.78
Antiviral targets of human noroviruses. Curr Opin Virol (2016) 0.77
Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data. J Comput Aided Mol Des (2010) 0.77
Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. PLoS Pathog (2016) 0.77
Characterization and control of surfactant-mediated Norovirus interactions. Soft Matter (2015) 0.77
Crystal structures of GI.8 Boxer virus P dimers in complex with HBGAs, a novel evolutionary path selected by the Lewis epitope. Protein Cell (2014) 0.77
Current tools for norovirus drug discovery. Expert Opin Drug Discov (2016) 0.76
Anti-norovirus therapeutics: a patent review (2010-2015). Expert Opin Ther Pat (2016) 0.76
Newly isolated mAbs broaden the neutralizing epitope in murine norovirus. J Gen Virol (2014) 0.76
Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A (2016) 0.75
Llama nanoantibodies with therapeutic potential against human norovirus diarrhea. PLoS One (2015) 0.75
Crystallization and X-ray analysis of 23 nm virus-like particles from Norovirus Chiba strain. Acta Crystallogr F Struct Biol Commun (2017) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature (1992) 36.50
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35
Norovirus classification and proposed strain nomenclature. Virology (2005) 7.69
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol (2003) 6.37
Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng (2001) 5.71
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology (2002) 4.13
Taxonomy of the caliciviruses. J Infect Dis (2000) 3.94
Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol (2006) 3.91
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol (2007) 3.58
The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis (2000) 3.29
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol (2005) 3.00
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Cation-pi interactions in ligand recognition and catalysis. Trends Pharmacol Sci (2002) 2.75
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol (2004) 2.68
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta (1999) 1.96
Organization and expression of calicivirus genes. J Infect Dis (2000) 1.94
Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J Virol (2004) 1.80
Mendelian resistance to human norovirus infections. Semin Immunol (2006) 1.77
Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71
Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis (2005) 1.68
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J Gen Virol (2005) 1.57
Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves. Vaccine (2005) 0.93
Norovirus gastroenteritis. N Engl J Med (2009) 7.66
Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09
Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15
Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49
The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38
Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38
Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09
Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05
Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89
Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 1.77
X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol (2006) 1.74
Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71
Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66
Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies. J Am Chem Soc (2011) 1.66
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65
Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63
Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56
Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51
Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43
Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43
Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Burden of illness in the first 3 years of life in an Indian slum. J Trop Pediatr (2009) 1.40
Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40
X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution. J Virol (2006) 1.37
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34
Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J Infect Dis (2006) 1.32
Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Res (2004) 1.31
Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol (2006) 1.30
Autophagy hijacked through viroporin-activated calcium/calmodulin-dependent kinase kinase-β signaling is required for rotavirus replication. Proc Natl Acad Sci U S A (2012) 1.30
Stem cell-derived human intestinal organoids as an infection model for rotaviruses. MBio (2012) 1.27
Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26
Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold. Nature (2002) 1.24
Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23
Interactions between the inner and outer capsids of bluetongue virus. J Virol (2004) 1.22
X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20
Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20
High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles. J Virol (2007) 1.15
Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin. Proc Natl Acad Sci U S A (2008) 1.15
Norwalk Virus Minor Capsid Protein VP2 Associates within the VP1 Shell Domain. J Virol (2013) 1.15
Rotavirus disrupts calcium homeostasis by NSP4 viroporin activity. MBio (2010) 1.13
Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10
Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infection. J Virol (2002) 1.10
VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol (2002) 1.10
Functional maturation of the human antibody response to rotavirus. J Immunol (2008) 1.09
Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system. Mol Biol Cell (2011) 1.08
Role of the histidine triad-like motif in nucleotide hydrolysis by the rotavirus RNA-packaging protein NSP2. J Biol Chem (2003) 1.07
Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol J (2006) 1.07
Inhibition of cellular protein secretion by norwalk virus nonstructural protein p22 requires a mimic of an endoplasmic reticulum export signal. PLoS One (2010) 1.07
Structure-function analysis of rotavirus NSP2 octamer by using a novel complementation system. J Virol (2006) 1.06
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies. J Med Chem (2011) 1.06
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Med Chem Lett (2013) 1.05
Norovirus vaccine development: next steps. Expert Rev Vaccines (2012) 1.03
Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs). Vaccine (2005) 1.01
The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol (2004) 1.01
Crystallization and preliminary crystallographic analysis of San Miguel sea lion virus: an animal calicivirus. J Struct Biol (2003) 1.00
Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99
Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor. J Virol (2010) 0.99
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Structural basis of substrate specificity and protease inhibition in Norwalk virus. J Virol (2013) 0.98